Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Radiopharm Theranostics Limited ( (AU:RAD) ) has provided an announcement.
Radiopharm Theranostics Limited has announced a proposed issue of securities under a securities purchase plan, offering a total of 166,666,667 new securities. This move is part of the company’s strategy to raise capital, potentially enhancing its financial position and supporting its ongoing projects in the radiopharmaceutical sector. The offer is set to close on November 28, 2025, with the issue date scheduled for December 5, 2025.
The most recent analyst rating on (AU:RAD) stock is a Buy with a A$0.05 price target. To see the full list of analyst forecasts on Radiopharm Theranostics Limited stock, see the AU:RAD Stock Forecast page.
More about Radiopharm Theranostics Limited
Radiopharm Theranostics Limited operates in the healthcare industry, focusing on the development and commercialization of radiopharmaceutical products. The company is involved in the production of diagnostic and therapeutic solutions, primarily targeting cancer treatment and imaging.
Average Trading Volume: 4,552,171
Technical Sentiment Signal: Buy
Current Market Cap: A$87.5M
See more data about RAD stock on TipRanks’ Stock Analysis page.